Cargando…

Identification of immune biomarkers in recent active pulmonary tuberculosis

Tuberculosis (TB) has remained an unsolved problem and a major public health issue, particularly in developing countries. Pakistan is one of the countries with the highest tuberculosis infection rates globally. However, methods or biomarkers to detect early signs of TB infection are limited. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaukat, Sobia Naz, Eugenin, Eliseo, Nasir, Faizan, Khanani, Rafiq, Kazmi, Shahana Urooj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352308/
https://www.ncbi.nlm.nih.gov/pubmed/37460564
http://dx.doi.org/10.1038/s41598-023-38372-7
_version_ 1785074485001453568
author Shaukat, Sobia Naz
Eugenin, Eliseo
Nasir, Faizan
Khanani, Rafiq
Kazmi, Shahana Urooj
author_facet Shaukat, Sobia Naz
Eugenin, Eliseo
Nasir, Faizan
Khanani, Rafiq
Kazmi, Shahana Urooj
author_sort Shaukat, Sobia Naz
collection PubMed
description Tuberculosis (TB) has remained an unsolved problem and a major public health issue, particularly in developing countries. Pakistan is one of the countries with the highest tuberculosis infection rates globally. However, methods or biomarkers to detect early signs of TB infection are limited. Here, we characterized the mRNA profiles of immune responses in unstimulated Peripheral blood mononuclear cells obtained from treatment naïve patients with early signs of active pulmonary tuberculosis without previous history of clinical TB. We identified a unique mRNA profile in active TB compared to uninfected controls, including cytokines such as IL-27, IL-15, IL-2RA, IL-24, and TGFβ, transcription factors such as STAT1 and NFATC1 and immune markers/receptors such as TLR4, IRF1, CD80, CD28, and PTGDR2 from an overall 84 different transcripts analyzed. Among 12 significant differentially expressed transcripts, we identified five gene signatures which included three upregulated IL-27, STAT1, TLR4 and two downregulated IL-24 and CD80 that best discriminate between active pulmonary TB and uninfected controls with AUC ranging from 0.9 to 1. Our data identified a molecular immune signature associated with the early stages of active pulmonary tuberculosis and it could be further investigated as a potential biomarker of pulmonary TB.
format Online
Article
Text
id pubmed-10352308
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-103523082023-07-19 Identification of immune biomarkers in recent active pulmonary tuberculosis Shaukat, Sobia Naz Eugenin, Eliseo Nasir, Faizan Khanani, Rafiq Kazmi, Shahana Urooj Sci Rep Article Tuberculosis (TB) has remained an unsolved problem and a major public health issue, particularly in developing countries. Pakistan is one of the countries with the highest tuberculosis infection rates globally. However, methods or biomarkers to detect early signs of TB infection are limited. Here, we characterized the mRNA profiles of immune responses in unstimulated Peripheral blood mononuclear cells obtained from treatment naïve patients with early signs of active pulmonary tuberculosis without previous history of clinical TB. We identified a unique mRNA profile in active TB compared to uninfected controls, including cytokines such as IL-27, IL-15, IL-2RA, IL-24, and TGFβ, transcription factors such as STAT1 and NFATC1 and immune markers/receptors such as TLR4, IRF1, CD80, CD28, and PTGDR2 from an overall 84 different transcripts analyzed. Among 12 significant differentially expressed transcripts, we identified five gene signatures which included three upregulated IL-27, STAT1, TLR4 and two downregulated IL-24 and CD80 that best discriminate between active pulmonary TB and uninfected controls with AUC ranging from 0.9 to 1. Our data identified a molecular immune signature associated with the early stages of active pulmonary tuberculosis and it could be further investigated as a potential biomarker of pulmonary TB. Nature Publishing Group UK 2023-07-17 /pmc/articles/PMC10352308/ /pubmed/37460564 http://dx.doi.org/10.1038/s41598-023-38372-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Shaukat, Sobia Naz
Eugenin, Eliseo
Nasir, Faizan
Khanani, Rafiq
Kazmi, Shahana Urooj
Identification of immune biomarkers in recent active pulmonary tuberculosis
title Identification of immune biomarkers in recent active pulmonary tuberculosis
title_full Identification of immune biomarkers in recent active pulmonary tuberculosis
title_fullStr Identification of immune biomarkers in recent active pulmonary tuberculosis
title_full_unstemmed Identification of immune biomarkers in recent active pulmonary tuberculosis
title_short Identification of immune biomarkers in recent active pulmonary tuberculosis
title_sort identification of immune biomarkers in recent active pulmonary tuberculosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352308/
https://www.ncbi.nlm.nih.gov/pubmed/37460564
http://dx.doi.org/10.1038/s41598-023-38372-7
work_keys_str_mv AT shaukatsobianaz identificationofimmunebiomarkersinrecentactivepulmonarytuberculosis
AT eugenineliseo identificationofimmunebiomarkersinrecentactivepulmonarytuberculosis
AT nasirfaizan identificationofimmunebiomarkersinrecentactivepulmonarytuberculosis
AT khananirafiq identificationofimmunebiomarkersinrecentactivepulmonarytuberculosis
AT kazmishahanaurooj identificationofimmunebiomarkersinrecentactivepulmonarytuberculosis